BRD4 amplification facilitates an oncogenic gene expression program in high-grade serous ovarian cancer and confers sensitivity to BET inhibitors

Garrett W. Rhyasen, Yi Yao, Jingwen Zhang, Austin Dulak, Lillian Castriotta, Kelly Jacques, Wei Zhao, Farzin Gharahdaghi, Maureen M. Hattersley, Paul D. Lyne, Edwin Clark, Michael Zinda, Stephen E. Fawell, Gordon B. Mills, Huawei Chen

    Research output: Contribution to journalArticlepeer-review

    8 Scopus citations

    Fingerprint Dive into the research topics of 'BRD4 amplification facilitates an oncogenic gene expression program in high-grade serous ovarian cancer and confers sensitivity to BET inhibitors'. Together they form a unique fingerprint.

    Chemical Compounds

    Medicine & Life Sciences

    Agriculture & Biology